vs
ASTRONICS CORP（ATRO）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
ASTRONICS CORP的季度营收约是Esperion Therapeutics, Inc.的1.4倍（$240.1M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 15.1%），过去两年ASTRONICS CORP的营收复合增速更高（13.9% vs 10.6%）
Astronics Corporation是一家成立于1968年的美国航空航天电子企业，总部位于纽约州东奥罗拉，在纳斯达克上市，股票代码为ATRO。该公司专注于军用、商用及公务机的照明与电子系统集成业务，同时还提供半导体测试系统，在相关领域拥有较高知名度。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
ATRO vs ESPR — 直观对比
营收规模更大
ATRO
是对方的1.4倍
$168.4M
营收增速更快
ESPR
高出128.6%
15.1%
两年增速更快
ATRO
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.1M | $168.4M |
| 净利润 | — | — |
| 毛利率 | 33.3% | — |
| 营业利润率 | 14.8% | 50.6% |
| 净利率 | — | — |
| 营收同比 | 15.1% | 143.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.82 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATROESPR
| Q4 25 | $240.1M | $168.4M | ||
| Q3 25 | $211.4M | $87.3M | ||
| Q2 25 | $204.7M | $82.4M | ||
| Q1 25 | $205.9M | $65.0M | ||
| Q4 24 | $208.5M | $69.1M | ||
| Q3 24 | $203.7M | $51.6M | ||
| Q2 24 | $198.1M | $73.8M | ||
| Q1 24 | $185.1M | $137.7M |
净利润ATROESPR
| Q4 25 | — | — | ||
| Q3 25 | $-11.1M | $-31.3M | ||
| Q2 25 | $1.3M | $-12.7M | ||
| Q1 25 | $9.5M | $-40.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-11.7M | $-29.5M | ||
| Q2 24 | $1.5M | $-61.9M | ||
| Q1 24 | $-3.2M | $61.0M |
毛利率ATROESPR
| Q4 25 | 33.3% | — | ||
| Q3 25 | 30.5% | — | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 28.0% | — | ||
| Q1 24 | 25.7% | — |
营业利润率ATROESPR
| Q4 25 | 14.8% | 50.6% | ||
| Q3 25 | 10.9% | -11.4% | ||
| Q2 25 | 2.3% | 8.6% | ||
| Q1 25 | 6.4% | -34.0% | ||
| Q4 24 | 4.3% | -6.4% | ||
| Q3 24 | 4.1% | -31.0% | ||
| Q2 24 | 3.8% | 3.5% | ||
| Q1 24 | 0.9% | 52.5% |
净利率ATROESPR
| Q4 25 | — | — | ||
| Q3 25 | -5.2% | -35.9% | ||
| Q2 25 | 0.6% | -15.4% | ||
| Q1 25 | 4.6% | -62.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.8% | -57.2% | ||
| Q2 24 | 0.8% | -83.9% | ||
| Q1 24 | -1.7% | 44.3% |
每股收益（稀释后）ATROESPR
| Q4 25 | $0.82 | $0.32 | ||
| Q3 25 | $-0.31 | $-0.16 | ||
| Q2 25 | $0.04 | $-0.06 | ||
| Q1 25 | $0.26 | $-0.21 | ||
| Q4 24 | $-0.07 | $-0.14 | ||
| Q3 24 | $-0.34 | $-0.15 | ||
| Q2 24 | $0.04 | $-0.33 | ||
| Q1 24 | $-0.09 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $167.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $140.1M | $-302.0M |
| 总资产 | $706.7M | $465.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATROESPR
| Q4 25 | $18.2M | $167.9M | ||
| Q3 25 | $13.5M | $92.4M | ||
| Q2 25 | $13.5M | $86.1M | ||
| Q1 25 | $24.8M | $114.6M | ||
| Q4 24 | $9.3M | $144.8M | ||
| Q3 24 | $5.2M | $144.7M | ||
| Q2 24 | $2.9M | $189.3M | ||
| Q1 24 | $5.3M | $226.6M |
股东权益ATROESPR
| Q4 25 | $140.1M | $-302.0M | ||
| Q3 25 | $108.9M | $-451.4M | ||
| Q2 25 | $271.6M | $-433.5M | ||
| Q1 25 | $266.8M | $-426.2M | ||
| Q4 24 | $256.1M | $-388.7M | ||
| Q3 24 | $249.2M | $-370.2M | ||
| Q2 24 | $257.9M | $-344.2M | ||
| Q1 24 | $251.7M | $-294.3M |
总资产ATROESPR
| Q4 25 | $706.7M | $465.9M | ||
| Q3 25 | $682.2M | $364.0M | ||
| Q2 25 | $646.7M | $347.1M | ||
| Q1 25 | $662.2M | $324.0M | ||
| Q4 24 | $648.8M | $343.8M | ||
| Q3 24 | $651.6M | $314.1M | ||
| Q2 24 | $644.9M | $352.3M | ||
| Q1 24 | $630.0M | $373.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.6M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $43.1M | — |
8季度趋势，按日历期对齐
经营现金流ATROESPR
| Q4 25 | $27.6M | $45.2M | ||
| Q3 25 | $34.2M | $-4.3M | ||
| Q2 25 | $-7.6M | $-31.4M | ||
| Q1 25 | $20.6M | $-22.6M | ||
| Q4 24 | $26.4M | $-35.0M | ||
| Q3 24 | $8.4M | $-35.3M | ||
| Q2 24 | $-6.3M | $-7.2M | ||
| Q1 24 | $2.0M | $53.8M |
自由现金流ATROESPR
| Q4 25 | $15.8M | — | ||
| Q3 25 | $21.0M | — | ||
| Q2 25 | $-12.2M | — | ||
| Q1 25 | $18.5M | — | ||
| Q4 24 | $23.2M | — | ||
| Q3 24 | $6.5M | $-35.5M | ||
| Q2 24 | $-8.1M | $-7.3M | ||
| Q1 24 | $439.0K | $53.8M |
自由现金流率ATROESPR
| Q4 25 | 6.6% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | -6.0% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 11.1% | — | ||
| Q3 24 | 3.2% | -68.7% | ||
| Q2 24 | -4.1% | -9.9% | ||
| Q1 24 | 0.2% | 39.0% |
资本支出强度ATROESPR
| Q4 25 | 4.9% | 0.0% | ||
| Q3 25 | 6.2% | 0.0% | ||
| Q2 25 | 2.2% | 0.0% | ||
| Q1 25 | 1.0% | 0.0% | ||
| Q4 24 | 1.5% | 0.0% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 0.9% | 0.1% | ||
| Q1 24 | 0.9% | 0.1% |
现金转化率ATROESPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -5.81× | — | ||
| Q1 25 | 2.17× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.08× | — | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
